Price movement over the last 24 hours
AbCellera Biologics Inc vs ThredUp Inc — how do they compare? AbCellera Biologics Inc trades at $7.2 (market cap $2.35B), while ThredUp Inc trades at $6.49 (market cap $882.64M). The key difference: AbCellera Biologics Inc is far larger — about 2.7× ThredUp Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, ThredUp Inc nearer its low. Which is the better fit depends on your goals.
| ABCL | TDUP | |
|---|---|---|
Market Cap | $2.35B | $882.64M |
Sector | Health | Consumer Cyclical |
52-Week High | $8.12 | $12.08 |
52-Week Low | $2.78 | $3.11 |
Enterprise Value | $1.99B | $885.37M |
Trailing returns across standard periods
Latest headlines on both assets
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →ThredUp Inc is an online resale platform for women and kids apparel, shoes, and accessories. It generates revenue from items that are sold to buyers through the website, mobile app, and RaaS partners.
Read more on TDUP →